Animal models of pulmonary emphysema: a stereologist's perspective

Fehrenbach H.

Source: Eur Respir Rev 2006; 15: 136-147
Journal Issue: December 2006 - 15 (101)
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Fehrenbach H.. Animal models of pulmonary emphysema: a stereologist's perspective. Eur Respir Rev 2006; 15: 136-147

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A novel non-human primate model of cigarette smoke-induced chronic obstructive pulmonary disease
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014

Effects of intermittent hypoxia on pulmonary haemodynamics: animal models versus studies in humans
Source: Eur Respir J 2005; 25: 173-180
Year: 2005



The immunomodulatory effect of protein S in pulmonary fibrosis
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013


Dilatation reserve of pulmonary arteries at stages of COPD experimental model
Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments
Year: 2013


Non-invasive monitoring of emphysema and muscle wasting during experimental disease exacerbation
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016

LATE-BREAKING ABSTRACT: Pneumonectomy combined with SU5416: a novel animal model of pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments
Year: 2013


Mepenzolate bromide displays beneficial effects in a mouse model of chronic obstructive pulmonary disease
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014


Stratified medicine: drugs meet genetics
Source: Eur Respir Rev 2013; 22: 53-57
Year: 2013



Pulmonary hypertension in COPD: results from the ASPIRE registry
Source: Eur Respir J 2013; 41: 1292-1301
Year: 2013



Pathology of chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=159
Year: 2006

Does Rosemary leaves extract can attenuate lung injury in experimental pulmonary fibrosis in rats?
Source: International Congress 2016 – ILD pathogenesis
Year: 2016


Effects of NecroX compounds on bleomycin-induced pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016


Formation of typical vascular lesions in a new experimental model of pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments
Year: 2013


Animal models of pulmonary hypertension in COPD
Source: Annual Congress 2010 - Pulmonary vascular involvement in COPD
Year: 2010


Role of survivin in experimental models of pulmonary arterial hypertension
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016

Specialized-proresolving mediators and trancriptomic signatures in bleomycin-induced lung fibrosis
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016

Distinct clinical phenotypes of airways disease defined by cluster analysis
Source: Eur Respir J 2009; 34: 812-818
Year: 2009



Elastase-induced emphysema is attenuated by L-carnitine supplementation
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015

Tools used to measure airway remodelling in research
Source: Eur Respir J 2007; 29: 596-604
Year: 2007